Antengene is a clinical-stage Asia-Pacific biopharmaceutical firm targeted on revolutionary oncology medicines. The firm affords industry-leading R&D capabilities and a differentiated strategic approach to creating novel oncology therapies.
The IPO was over-subscribed greater than 264 occasions on the Hong Kong public providing, raised over HK$2.6 billion (US$335 million), and listed on 20 November 2020. The providing attracted 10 cornerstone traders that subscribed to shares value roughly HK$1.39 billion in complete (roughly US$179 million).
“This year has been notable for the wave of healthcare listings in Hong Kong,” mentioned Hong Kong companion Matt Emsley. “It is encouraging to see repeated healthcare listings attract investors, since the introduction of the Listing Rules’ Chapter 18A biotech/pharma changes in 2018.”
“We are delighted to have advised Goldman Sachs and JP Morgan on this IPO, congratulate Antengene on its IPO, and look forward to its continued success,” mentioned Herbert Smith Freehills Kewei joint operation companion Stanley Xie. “This is one of nearly a dozen Hong Kong IPOs on which Herbert Smith Freehills Kewei Joint Operation Office has assisted since its establishment just over one year ago.”
Herbert Smith Freehills has now suggested on a variety of healthcare listings for the reason that Hong Kong trade launched its new regime for biotech listings in 2018, together with listings by Shanghai Junshi Biosciences (01877.HK), TOT BIOPHARM (01875.HK), SinoMab Bioscience Limited (03681.HK), Peijia Medical (09996.HK) and Simcere Pharmaceutical (02096.HK).
Matt and Stanley led the workforce advising the sponsors, assisted by senior associates Jin Kong and Maisie Ko, associates Jaime Fong, Tracy Lee and Karen Liu, authorized supervisor Jeffrey Lee in Hong Kong, and affiliate Sean Ji from Herbert Smith Freehills Kewei. Hong Kong trainees Rachel Lam, Joyce Chan and Troy Song, as well as paralegal Jessica Sun from Herbert Smith Freehills Kewei, additionally supplied assist.
Senior authorized specialist Joanna Hu led Herbert Smith Freehills Kewei Joint Operation’s Alternative Legal Services companies to supply high-efficiency options for document-intensive processes throughout the providing, assisted by senior authorized analysts Selina Wang and Yuanyuan Yin as well as authorized analyst Shawna Peng. Senior authorized analyst Ellie Mao, lawyer Helen Liang and authorized specialist Yilin Li additionally supplied assist. The Alternative Legal Services companies are the one operations of their form in mainland China.